Phenotypic Variability in Jordan’s Syndrome

Introduction: PPP2R5D-Related Neurodevelopmental Disorder or Jordan’s syndrome is a very rare autosomal dominant condition, with about 100 cases reported, with a complex phenotype including global developmental delay, seizures, macrocephaly, ophthalmological abnormalities, hypotonia, attention disorder, autism, and feeding difficulties. In this paper, we will report on two cases of Jordan’s syndrome with a different clinical picture.

Method: The first patient is a 2-year-and-8-month-old girl with drug-resistant epilepsy, severe developmental delay, macrocephaly, megalencephaly, axial hypotonia, and dysmorphic features. The second patient is a 5-year-old boy with autism spectrum disorder, hyperkinesia, and speech delay. Both patients underwent genetic testing by WES.

Results: In both children, heterozygous pathogenic variants of PPP2R5D were identified: c.592G>A (p. Glu198Lys) in the first case, and c.598G>A (p. Glu200Lys) in the second case. Phenotype-genotype correlations were reported in Jordan’s syndrome. Thus, epileptic seizure and a greater cognitive impairment were more often associated with p. Glu198Lys variant, while persons with p. Glu200Lys have a better cognitive development, with more common behavior problems (aggression, opposition).

Conclusions: Jordan’s syndrome is a complex condition, with neuropsychiatric manifestations being the most common features, including developmental delay, epilepsy, and behavioral problems. The severity of the phenotype is correlated with the PPP2R5D gene variant; thus, the genetic test may have a prognostic role in the management plan of these patients.

Acknowledgment: This work was performed under the Project No. 15CoEx/2026 “Mental health in a rapidly changing society: A multi-level approach, from genes and molecules to neural networks and psychosocial systems”, (RoMentalHealth), PN-IV-P6-6.1-CoEx-2024-0139.